{
    "organizations": [],
    "uuid": "47116762d525bde427e7cf6683615e3d0f0d7dd9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-diurnal-says-european-commission-g/brief-diurnal-says-european-commission-granted-paediatric-use-marketing-authorisation-for-alkindi-idUSFWN1Q30BJ",
    "ord_in_thread": 0,
    "title": "Diurnal Says European Commission Granted Paediatric Use Marketing Authorisation For Alkindi",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Diurnal Group Plc:\n* EUROPEAN COMMISSION HAS GRANTED A PAEDIATRIC USE MARKETING AUTHORISATION FOR ALKINDI\n* ANTICIPATE FIRST LAUNCH OF ALKINDI IN Q2 2018 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ",
    "published": "2018-02-13T15:17:00.000+02:00",
    "crawled": "2018-02-14T12:30:29.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "diurnal",
        "group",
        "plc",
        "european",
        "commission",
        "granted",
        "paediatric",
        "use",
        "marketing",
        "authorisation",
        "alkindi",
        "anticipate",
        "first",
        "launch",
        "alkindi",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}